The British shoe manufacturer Dr Martens' share is plummeting on the London Stock Exchange since the investment bank Goldman Sachs sold a large stake in the company at a significant discount.
When the London Stock Exchange opened on Friday, the share plummeted by 13 percent.
Dr Martens has issued two profit warnings in one year, citing bottlenecks in supply chains, and in April, CEO Kenny Wilson announced that he is leaving.
Since the turn of the year, the share has lost 37 percent of its value.
